This article is more than 5 years old. Information may no longer be current.

Second Sight reports 163% increase in total revenue in 2015

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Second Sight reported $8.9 million in total revenue in 2015, a 163% increase from $3.4 million reported in 2014, according to a press release.

The increase was attributed to a higher number of Argus II retinal prostheses implanted in 2015.

Net loss was reported at $20 million, or $0.56 per share, compared with $35.2 million, or $1.41 per share, in 2014.

Total cost of operating expenses was reported at $23.7 million in 2015 compared with $21.1 million in 2014.

The increase was attributed to additional investments in the business and clinical and regulatory expenses related to the launch of the company’s dry age-related macular degeneration trial in the United Kingdom.